Apyx Medical Corporation
APYX | NASDAQ
$2.94
+$0.03 (+1.03%)
Sep 22, 2026, 11:55 AM ET · Market open
Market Data
Market Cap $122.54M
Enterprise Value $134.55M
Beta 1.31
Average Volume 153.81K
Shares Outstanding (Diluted) N/A
Shares Change YoY 3.52%
Institutional Ownership 49.36%
Exchange NASDAQ
ISIN US03837C1062
Price Performance
Price Change 1M -7.0%
Price Change 3M -28.7%
Price Change 6M -25.2%
Price Change YTD -16.9%
Price Change 1Y 44.1%
Price Change 3Y -9.6%
Price Change 5Y -76.7%
1M CAGR (ann.) -28.1%
1Y CAGR (ann.) 29.9%
5Y CAGR (ann.) -23.3%
All-Time CAGR -9.8%
Valuation
PE Ratio -14.55
Forward PE N/A
PEG Ratio -0.15
Forward PEG 2.74
PS Ratio 2.10
Forward PS 1.90
PB Ratio 11.49
P/FCF Ratio -10.49
P/Adj. FCF Ratio -9.03
P/OCF Ratio -12.13
EV/Sales 2.30
EV/EBIT -56.35
EV/EBITDA -73.41
EV/FCF -11.52
Earnings Yield -6.9%
FCF Yield -9.5%
Adj. FCF Yield -11.1%
Financial Health
Net Debt $7.71M
Total Debt $39.63M
Cash & Short-Term Investments $27.62M
Total Assets $61.07M
Current Ratio 5.68
Quick Ratio 4.53
Debt / Equity Ratio 3.72
Debt / EBITDA -21.62
Debt / FCF -3.39
OCF / Debt -0.27
Interest Coverage -0.63
Altman Z-Score 0.99
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 33.9%
Operating Profit Margin -6.1%
EBITDA Margin -2.8%
Net Profit Margin -14.8%
FCF Margin -20.0%
Adj. FCF Margin -23.2%
SBC / Revenue 3.2%
SBC Impact (per share) -16.2%
Returns
Return on Assets -14.1%
Return on Equity -78.7%
Return on Invested Capital -6.8%
Return on Capital Employed -6.8%
Return on Tangible Assets -14.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 7.2%
Revenue CAGR 5Y 8.8%
Revenue CAGR 10Y 5.8%
EPS CAGR 3Y 62.4%
EPS CAGR 5Y 12.6%
EPS CAGR 10Y -44.4%
FCF CAGR 3Y -18.4%
FCF CAGR 5Y 11.1%
FCF CAGR 10Y 0.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.07
EPS Growth Est (next Q) 40.0%
Revenue Est (next Q) $13.3M
Revenue Growth Est (next Q) 3.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7
Price Target Upside 140.5%
Cash Flow
Operating Cash Flow $-10.7M
Free Cash Flow $-11.68M
Adj. Free Cash Flow $-13.57M
FCF Per Share -$0.26
OCF Per Share -$0.24
OCF/S Ratio -17.3%
Income Statement
Revenue $58.42M
Gross Profit $19.83M
Operating Income $-3.54M
EBITDA $-1.83M
Net Income $-8.63M
EPS (Diluted) -$0.20
Revenue / Employee $284.95K
Profit / Employee $-42.12K
Employees 205
Add to Watchlist
Select watchlists to add or remove APYX